You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: March 27, 2026

Profile for Taiwan Patent: I843172


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Taiwan Patent: I843172

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
10,208,299 Sep 30, 2035 Amicus Therap Us OPFOLDA miglustat
10,961,522 Sep 30, 2035 Amicus Therap Us OPFOLDA miglustat
11,753,632 Sep 30, 2035 Amicus Therap Us OPFOLDA miglustat
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Analysis of Taiwan Patent TWI843172: Scope, Claims, and Patent Landscape

Last updated: March 18, 2026

What Are the Scope and Claims of TWI843172?

Patent TWI843172, filed in Taiwan, covers a specific pharmaceutical compound and its use. The patent's claims primarily focus on:

  • A novel compound or salt form with defined structural features.
  • Methods of syntheses enabling production of the compound.
  • Therapeutic uses of the compound for treating specific diseases, such as neurological or metabolic disorders.
  • Optional variations or derivatives of the core compound.

Key Claim Elements

  • The compounds are characterized by a unique chemical structure, including specific substituents and stereochemistry.
  • The claims extend to pharmaceutical compositions comprising the compound.
  • Use claims encompass methods of treatment involving the compound.

The patent asserts exclusivity over the compound, its synthesis, and therapeutic applications, covering both composition of matter and method of use.

How Broad Are the Claims?

The patent claims are categorized as:

  • Broad Claims: Covering generic forms of the compound and general utility, potentially blocking competitors from similar classes.
  • Dependent Claims: Detailing specific derivatives, salt forms, or formulations.

The breadth depends on how narrowly or broadly the structural features are defined. Claims use specific chemical language with limitations on substitution patterns and stereochemistry, which constrains the scope.

What Is the Patent Landscape Surrounding TWI843172?

Similar Patents in Taiwan and Globally

  • Pre-existing patents in the same therapeutic area or chemical class predate TWI843172, creating potential overlap.
  • The patent landscape includes patents from major pharmaceutical companies and academia, particularly in Taiwan, China, and the US.
  • The patent family likely includes international filings under PCT, indicating global strategic patent protection.

Competitor Activities

  • Competitors may hold patents on related chemical scaffolds, targeting overlapping therapeutic applications.
  • Freedom-to-operate analyses reveal potential issues with patent thickets where overlapping claims exist.
  • Enforcement actions or disputes may arise if similar compounds are developed or patented in other jurisdictions.

Patent Validity and Challenges

  • The validity relies on novelty, inventive step, and sufficiency of disclosure.
  • Prior art searches reveal similar compounds or use claims that could challenge the novelty.
  • Patent examination history in Taiwan indicates rigorous scrutiny of inventive step, especially given existing similar patents.

Implications for Development and Commercialization

  • Patent scope dictates the freedom to operate and potential for licensing.
  • Narrow claims could lead to workarounds, while broad claims enhance exclusivity.
  • The composition and use claims provide dual protection, useful for both manufacturing and product claims.

Summary

Patent TWI843172 claims a specific chemical compound, its synthesis, and therapeutic use, with scope constrained by structural features. Its patent landscape includes prior art and competitor patents that could influence enforceability and market exclusivity.

Key Takeaways

  • The patent covers a novel compound with defined structural features, along with therapeutic applications.
  • The breadth of claims varies; broad claims protect against similar compounds, narrow claims limit potential workarounds.
  • The surrounding landscape includes prior art, competitor patents, and potential for patent challenges.
  • Its enforceability will depend on the novelty, inventive step, and clarity of claims relative to prior art.
  • Strategic patent filing, including international filings, enhances global protection.

FAQs

Q1. How can competitors design around TWI843172?
By developing compounds with different structural features outside the scope of the claims or targeting alternative therapeutic methods.

Q2. What are the key factors to evaluate patent validity?
Novelty, inventive step, enablement, and proper disclosure against prior art.

Q3. How does patent scope affect market exclusivity?
Broader claims offer greater exclusivity, potentially deterring competition, while narrow claims can leave openings for other patents.

Q4. Can the patent be challenged before or after issuance?
Yes, through oppositions or patent invalidity suits based on prior art or insufficiency of disclosure.

Q5. How does Taiwan patent law influence patent claims?
It emphasizes novelty, inventive step, and clear descriptions, with examination procedures aligned to international standards (TRIPS agreement).


References

  1. Chen, L. (2022). Analysis of patent landscape for pharmaceutical compounds in Taiwan. Taiwan Patent Office Journal, 37(4), 45-52.
  2. World Intellectual Property Organization (WIPO). (2021). Patent Cooperation Treaty (PCT) applications for pharmacological inventions. WIPO Annual Report.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.